top of page

Infectious Disease & Sepsis

Public·502 members

Mazen Kherallah

Mazen Kherallah

December 30, 2024

A phase III randomized controlled non-inferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) versus piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) - International Journal of Infectious Diseases

ree

116 Views

Members

Abdullah
Abdullah
drkasgov
drkasgov
Nader Guma
Nader Guma
Salah Safieldeen
Pioneer
Mahir Al Bahrani
Mahir Al Bahrani

See All Members (502)

bottom of page